DOC Healthpeak Properties (DOC) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0000765880
Congress · 1
Insider buyers, 180 days
0
Funds added, last quarter
344
13F, latest reported quarter
What the filings say about DOC
Insiders, 180 days
-$213.7K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 1 sold
Latest: sale, 2026-02-10
Healthpeak Properties insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HEALTHPEAK PROPERTIES, INC. insiders sold a net $213.7K of stock across 32 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 143.9% of the 7,636 shares held after it.
- No other insider sold within 30 days.
- 344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CDO and Head of Lab Bohn Scott R sold about $213.7K of DOC on May 12, 2026, the largest insider sale at the company since 2023; 344 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (1 buy, 5 sales), the last on Apr 28, 2025.
- The trade is 0.2% of the 810,016 shares held after it.
- 1 other insider bought within 30 days.
- 344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Thomas John T bought about $24.7K of DOC on Aug 6, 2025; 1 other insider bought within 30 days and 344 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Jul 31, 2025.
- +2.2% median (+3.9% mean) 90-day return after 4 previous buys.
- The trade is 0.7% of the 211,906 shares held after it.
- 1 other insider bought within 30 days.
- 344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Brinker Scott M bought about $25.1K of DOC on Aug 4, 2025; 1 other insider bought within 30 days and 344 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Jul 28, 2025.
- -1.1% median (+3.3% mean) 90-day return after 3 previous buys.
- The trade is 1.4% of the 210,416 shares held after it.
- 1 other insider bought within 30 days.
- 344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Brinker Scott M bought about $50.0K of DOC on Jul 31, 2025; 1 other insider bought within 30 days and 344 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 9, 2025.
- -1.2% median (-1.2% mean) 90-day return after 2 previous buys.
- The trade is 1.4% of the 207,486 shares held after it.
- 1 other insider bought within 30 days.
- 344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Brinker Scott M bought about $50.0K of DOC on Jul 28, 2025; 1 other insider bought within 30 days and 344 funds added in the latest 13F quarter.32 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$213.7K over 180 days
below 62% of Real Estate
Congress
1 member bought in the last year
the lowest in Real Estate
Funds
344 funds bought in last quarter
more than 87% of Real Estate
Revenue
+6.2% year over year
more than 58% of Real Estate
Margin
11.8% net margin
more than 56% of Real Estate
Buybacks
$101.6M repurchased, FY to 2026-06-30
more than 83% of Real Estate
Short interest
3.4% of the float short (float per yahoo 2026-10-26) · 3.8 days to cover · settled 2026-09-30
below 56% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch DOC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+8.8%12M
Insider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns DOC: institutional holders (13F)
13F holdings, latest reported quarter
70,935,046 sh
$1.5B
58,375,816 sh
$1.2B
45,014,755 sh
$963.3M
44,007,417 sh
$941.8M
30,192,317 sh
$661.0M
Congress trades in DOC
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-02-10 · disclosed 27 days later
$1,001 - $15,000
Bought 2026-01-09 · disclosed 35 days later
$1,001 - $15,000
Sold 2025-08-04 · disclosed 39 days later
$1,001 - $15,000
Bought 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Sold 2025-05-15 · disclosed 25 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
DOC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
DOC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
BNY Mellon Global Infrastructure Income ETF
$88.5M position · as of 2026-07-31
6.8%
Long Pond Real Estate Select ETF
$10.1M position · as of 2026-05-31
6.4%
SRH REIT Covered Call ETF
$3.1M position · as of 2026-07-31
5.8%
FULLERTHALER BEHAVIORAL MID-CAP VALUE
$18.5M position · as of 2026-06-30
5.5%
Undiscovered Managers Behavioral Value Fund
$479.6M position · as of 2026-06-30
5.3%
Davis Real Estate Fund
$5.0M position · as of 2026-06-30
4.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $213.7K sold by insiders over 180 days, 344 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
DOC financials
Revenue growth
+6.2%
XBRL, annual
Net margin
11.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM DOC
| FY Dec 2025 | $2.8B |
| FY Dec 2024 | $2.7B |
| FY Dec 2023 | $2.2B |
| FY Dec 2022 | $2.1B |
| FY Dec 2021 | $1.9B |
| Jun 2026 | $771.6M |
| Mar 2026 | $753.0M |
| Dec 2025 | $719.4M |
| Sep 2025 | $705.9M |
| Jun 2025 | $694.3M |
| Mar 2025 | $702.9M |
| Dec 2024 | $698.0M |
| Sep 2024 | $700.4M |
At each fiscal year end
Single quarter
Net margin, TTM
+8.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM DOC
| FY Dec 2025 | +2.5% |
| FY Dec 2024 | +9.0% |
| FY Dec 2023 | +14.0% |
| FY Dec 2022 | +24.3% |
| FY Dec 2021 | +26.7% |
| Jun 2026 | +6.8% |
| Mar 2026 | +25.7% |
| Dec 2025 | +15.8% |
| Sep 2025 | -16.6% |
| Jun 2025 | +4.6% |
| Mar 2025 | +6.1% |
| Dec 2024 | +0.7% |
| Sep 2024 | +12.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM DOC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
1.28x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity DOC
| FY Dec 2025 | 1.31x |
| FY Dec 2024 | 1.04x |
| FY Dec 2023 | 1.08x |
| FY Dec 2022 | 0.98x |
| FY Dec 2021 | 0.95x |
| Jun 2026 | 1.28x |
| Mar 2026 | 1.33x |
| Dec 2025 | 1.31x |
| Sep 2025 | 1.20x |
| Jun 2025 | 1.14x |
| Mar 2025 | 1.08x |
| Dec 2024 | 1.04x |
| Sep 2024 | 1.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.12x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt DOC
| FY Dec 2025 | 0.13x |
| FY Dec 2024 | 0.12x |
| FY Dec 2023 | 0.14x |
| FY Dec 2022 | 0.14x |
| FY Dec 2021 | 0.13x |
| Jun 2026 | 0.12x |
| Mar 2026 | 0.12x |
| Dec 2025 | 0.13x |
| Sep 2025 | 0.14x |
| Jun 2025 | 0.14x |
| Mar 2025 | 0.13x |
| Dec 2024 | 0.12x |
| Sep 2024 | 0.12x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity DOC
| FY Dec 2025 | +0.9% |
| FY Dec 2024 | +3.3% |
| FY Dec 2023 | +4.7% |
| FY Dec 2022 | +7.6% |
| FY Dec 2021 | +7.6% |
| Jun 2026 | +3.1% |
| Mar 2026 | +2.8% |
| Dec 2025 | +0.9% |
| Sep 2025 | -0.5% |
| Jun 2025 | +2.0% |
| Mar 2025 | +3.3% |
| Dec 2024 | +3.3% |
| Sep 2024 | +4.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets DOC
| FY Dec 2025 | +0.4% |
| FY Dec 2024 | +1.4% |
| FY Dec 2023 | +1.9% |
| FY Dec 2022 | +3.2% |
| FY Dec 2021 | +3.2% |
| Jun 2026 | +1.2% |
| Mar 2026 | +1.1% |
| Dec 2025 | +0.4% |
| Sep 2025 | -0.2% |
| Jun 2025 | +0.8% |
| Mar 2025 | +1.4% |
| Dec 2024 | +1.4% |
| Sep 2024 | +1.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital DOC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed DOC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
55.00x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing DOC
| FY Dec 2025 | 160.80x |
| FY Dec 2024 | 59.62x |
| FY Dec 2023 | 35.36x |
| FY Dec 2022 | 27.25x |
| FY Dec 2021 | 38.81x |
| Jun 2026 | 61.14x |
| Mar 2026 | 51.34x |
| Dec 2025 | 160.80x |
| Sep 2025 | n/a |
| Jun 2025 | 76.13x |
| Mar 2025 | 51.85x |
| Dec 2024 | 59.62x |
| Sep 2024 | 48.66x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$21.7B
market value at close 2026-10-23 on 2026-08-03 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value DOC
| FY Dec 2025 | $20.6B |
| FY Dec 2024 | $22.8B |
| FY Dec 2023 | $17.6B |
| FY Dec 2022 | $19.9B |
| FY Dec 2021 | $25.5B |
| Jun 2026 | $23.2B |
| Mar 2026 | $20.7B |
| Dec 2025 | $20.6B |
| Sep 2025 | $22.3B |
| Jun 2025 | $21.1B |
| Mar 2025 | $23.0B |
| Dec 2024 | $22.8B |
| Sep 2024 | $24.4B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield DOC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.05x
P/E over trailing EPS growth of 52%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing DOC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 2.02x |
| Jun 2026 | 1.17x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 4.54x |
| Dec 2024 | n/a |
| Sep 2024 | 7.14x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.2B | $2.1B |
| Net income | $71.3M | $243.1M | $306.0M | $500.4M |
| EPS (diluted) | 0.10 | 0.36 | 0.56 | 0.92 |
| Operating cash flow | $1.3B | $1.1B | $956.2M | $900.3M |
| Cash | $467.5M | $119.8M | $117.6M | $72.0M |
| Long-term debt | $9.8B | $8.7B | $6.9B | $6.5B |
| Buybacks | $97.1M | $190.7M | $6.5M | $67.8M |
| Dividends paid | $849.1M | $794.8M | $657.0M | $648.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
DOC Stock Sonar score 6/7 axes
Find similar shapesCompareDOC ranks highest on institutional and government (59th percentile) and growth (58th), and lowest on insider conviction (19th), among Real Estate peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DOC filings, in plain words
Are Healthpeak Properties insiders buying or selling DOC?
In the 180 days to 2026-10-27, Healthpeak Properties insiders were net sellers, a net $213.7K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded DOC?
Yes. In the year to 2026-10-27, 1 House member disclosed buying DOC and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-02-10.
Read the full summary
In the 180 days to 2026-10-27, Healthpeak Properties insiders were net sellers of DOC, a net $213.7K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-27, 1 member of Congress disclosed buying DOC and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-02-10. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
